In vitro effects of aminoglycosides and fluoroquinolones on keratocytes

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 4, 1996, Pages 656-665

  Seitz, Berthold ^a,b   Hayashi, Seiji ^a   Wee, Won Ryang ^a,c   LaBree, Laurie ^d   McDonnell, Peter J ^a,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

antibiotics; antiproliferative effects; corneal stroma; cytotoxicity; keratocytes

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; DRUG CYTOTOXICITY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RABBIT;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CELL DIVISION; CELLS, CULTURED; CORNEA; CORNEAL STROMA; DNA; DNA REPLICATION; EPITHELIAL CELLS; EPITHELIUM; FLUOROQUINOLONES; MICROSCOPY, PHASE-CONTRAST; RABBITS; THYMIDINE;

EID: 0029871498     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Epstein D, Fagerholm P, Hamberg-Nyström H, Tengroth B. Twenty-four-month follow-up of excimer laser photorefractive keratectomy for myopia: Refractive and visual acuity results. Ophthalmology. 1994;101: 1558-1564.
2. Maguen E, Salz JJ, Nesburn, et al. Results of excimer laser photorefractive keratectomy for the correction of myopia. Ophthalmology. 1994;101:1548-1557.
3. Tengroth B, Epstein D, Fagerholm P, Hamberg-Nyström H, Fitzsimmons TD. Excimer laser photorefractive keratectomy for myopia: Clinical results in sighted eyes. Ophthalmology. 1993;100:739-745.
4. Gartry DS, Muir MK, Marshall J. Excimer laser photorefractive keratectomy: 18-month follow-up. Ophthalmology. 1992;99:1209-1219.
5. Seiler T, Holschbach A, Derse M, Jean B, Genth U. Complications of myopic photorefractive keratectomy with the excimer laser. Ophthalmology. 1994;101:153-160.
6. Gadebusch HH, Shungu DL. Norfloxacin, the first of a new class of fluoroquinolone antimicrobials, revisited. Int J Antimicrob Agents. 1991;1:3-28.
7. Walker RC, Wright AJ. Symposium on antimicrobial agents: The quinolones. Mayo Clin Proc. 1987;62: 1007-1012.
8. Serdarevic ON. Role of fluoroquinolones in ophthalmology. Int Ophthalmol Clin. 1993;33:163-178.
9. Miller IM, Vogel R, Cook TJ, Wittenreich J, The Worldwide Norfloxacin Ophthalmic Study Group. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. Am J Ophthalmol. 1992;113:638-644.
10. Gwon A, for the Ofloxacin Study Group II. Ofloxacin vs tobramycin for the treatment of external ocular infection. Arch Ophthalmol. 1992;110:1234-1237.
11. Cokingtin CD, Hyndiuk RA. Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections.Am J Ophthalmol. 1991;112:25S-28S.
12. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 1991;112:34S-47S.
13. Osato MS, Jensen HG, Trousdale MD, et al. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989;108:380-386.
14. Wilhelmus KR, Gilbert ml, Osato MS. Tobramycin in ophthalmology. Surv Ophthalmol. 1987;32:111-122.
15. Records RE. Gentamicin in ophthalmology. Surv Ophthalmol. 1976;21:49-58.
16. Crumplin GC. The Mechanism of Action of Quinolones. In: Percival A, ed. Quinolones - Their Future in Clinical Practise. London: Royal Society of Medicine Service; 1986:1-14.
17. Cutarelli PE, Lazarus HM, Jacobs MR, Lass JH. Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens. Curr Eye Res. 1993;12:603-608.
18. Nakamura M, Nishida T, Mishima H, Otori T. Effects of antimicrobials on corneal epithelial migration. Curr Eye Res. 1993;12:733-740.
19. Cutarelli PE, Lass JH, Lazarus HM, Putman SC, Jacobs MR. Topical fluoroquinolones: Antimicrobial activity and in vitro corneal epithelial toxicity. Curr Eye Res. 1991;10:557-563.
20. Alfonso EC, Albert DM, Kenyon KR, Robinson NL, Hanninen L, D'Amico DJ. In vitro toxicity of gentamicin to corneal epithelial cells. Cornea. 1990;9:55-61.
21. Nelson JD, Silverman V, Lima PH, Beckman G. Corneal epithelial wound healing: A tissue culture assay on the effects of antibiotics. Curr Eye Res. 1990;9:277-285.
22. Lass JH, Mack RJ, Imperia PS, Mallick K, Lazarus HM. An in vitro analysis of aminoglycoside corneal epithelial toxicity. Curr Eye Res. 1989;8:299-304.
23. Petroutsos G, Guimaraes R, Giraud J, Pouliquen Y. Antibiotics and corneal epithelial wound healing. Arch Ophthalmol. 1983;101:1775-1778.
24. Stern GA, Schemmer GB, Farber RD, Gorovoy MS. Effect of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol. 1983;101:644-647.
25. Purnell WD, McPherson SD. The effect of tobramycin on rabbit eyes. Arch Ophthalmol. 1974;77:578-582.
26. Marr WG, Wood R, Grieves M. Further studies on the effect of agents on regeneration of corneal epithelium. Am J Ophthalmol. 1954;37:544-548.
27. Fischer AB. Gentamicin as a bactericidal antibiotic in tissue culture. Med Microbiol Immunol. 1975;161:23-39.
28. Schafer TW, Pascale A, Shimonaski G, Came PE. Evaluation of gentamicin for use in virology and tissue culture. Appl Microbiol. 1972;23:565-570.
29. Rudin A, Healey A, Phillips CA, Gump DW, Forsyth BR. Antibacterial activity of gentamicin sulfate in tissue culture. Appl Microbiol. 1970;20:989-900.
30. Libert J, Ketelbant-Balasse PE, Van Hoof F, Aubert-Tulkens G, Tulkens P. Cellular toxicity of gentamicin. Am J Ophthalmol. 1979;87:405-411.
31. Litwin J. The effect of antibiotics on the growth and longevity of human diploid fibroblasts in vitro. Acta Pathol Microbiol Scand (Section B). 1973;81:593-605.
32. Kanellopoulos AJ, Miller F, Wittpenn JR. Deposition of topical ciprofloxacin to prevent reepithelialization of a corneal defect. Am J Ophthalmol. 1994;117:258-259.
33. Campos M, Szerenyi K, Lee M, McDonnell JM, Lopez PF, McDonnell PJ. Keratocyte loss after corneal deepithelialization in primates and rabbits. Arch Ophthalmol. 1994;112:254-60.
34. Szerenyi KD, Wang XW, Gabrielian K, McDonnell PJ. Keratocyte loss and repopulation of anterior corneal stroma after de-epithelialization. Arch Ophthalmol. 1994;112:973-976.
35. Swan KC, White NG. Corneal permeability. Am J Ophthalmol. 1942;25:1043-1057.
36. McDermott ml, Tran TD, Cowden JW, Buggé CJ. Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmology. 1993;100:197-200.
37. Price FW Jr, Whitson WE, Collins KS, Gonzales JS. Corneal tissue levels of topically applied Ciprofloxacin. Cornea. 1995;14:152-156.
38. Borrmann L, Tang-Liu DDS, Kann J, Nista J, Lin ET, Frank J. Ofloxacin in human serum, urine, and tear film after topical application. Cornea. 1992;11:226-230.
39. Grayson G, Flowers C, Nassaralla B, Dewan N, Esrail R, McDonnell PJ. Aqueous penetration of 0.3% ciprofloxacin and 0.3% ofloxacin after topical application and a microbial analysis of pretreatment conjunctiva and post-treatment aqueous humor. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1995;36:S160.
40. Huber-Spitzy VN, Czejka M, Georgiew L, Arocker-Mettinger E, Grabner G. Penetration of norfloxacin into the aqueous humor of the human eye. Invest Ophthalmol Vis Sci. 1992;33:1723-1726.
41. Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. Ophthalmology. 1994;101:902-905.
42. Wu WC, Stark WJ, Green WR. Corneal would healing after 193-nm excimer laser keratectomy. Arch Ophthalmol. 1991;109:1426-1432.
43. Fantes FE, Hanna KD, Waring GO III, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990;108:665-675.